QUINTA-ANALYTICA, as part of Conscio Group, along with our network of companies, is looking forward to reconnecting with our current partners and friends, as well as establishing new collaborations at the pharmaceutical event of the year.

Visit us at the Conscio Group booth 22G4 in the Integrated Pharma Hall to explore how our combined expertise can drive drug development in innovative formulations, pharmaceutical research, analytical solutions for pharmaceuticals and biologics, and clinical development, including trials and bioanalysis.

You’ll also have the opportunity to meet our strategic partner, Kiel Laboratories, based in USA, who specializes in supporting pharmaceutical companies in bringing new drugs to market, particularly through the 505(b)(2) process of the US-FDA approval.

If you’re interested in arranging a meeting with us, please reach out to your business representative or send an email to sales@quinta.cz, and we will schedule a time slot for you.

Additional News

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.